Malignancies in Women with HIV Infection
Open Access
- 1 July 2008
- journal article
- review article
- Published by SAGE Publications in Women's Health
- Vol. 4 (4) , 357-368
Abstract
Women with HIV infection have an increased risk of developing certain malignancies. These malignancies are commonly human papillomavirus (HPV)-related, reflecting the high rate of coinfection with HPV in women with underlying HIV infection. These women also have a high incidence of premalignant HPV-related changes, such as high-grade squamous intraepithelial lesions as diagnosed on Pap smears and cervical intraepithelial neoplasia on cervical biopsy. Screening recommendations for HIV-infected women reflect the need for vigilance in detecting and treating these lesions early. In addition, recent interest has focused on the use of cervical cancer screening, employing HPV-testing techniques, and on HPV vaccination in younger women to prevent initial infection and the subsequent development of cervical and other HPV-related cancers. The incidence of other types of malignancies, such as Hodgkin's and non-Hodgkin's lymphoma, is also increased in HIV-infected individuals. When these lymphomas occur, they tend to be of advanced stage and high-grade histologies. The advent of highly active antiretroviral therapy has been associated with a marked decrease in the incidence of some of these cancers. The use of therapy has been associated with marked improvement in response rates and overall survival of affected patients.Keywords
This publication has 68 references indexed in Scilit:
- HPV testing for primary cervical cancer screeningThe Lancet, 2007
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDSBlood, 2006
- Hodgkin lymphoma: to the HAART of the matterBlood, 2006
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI: Journal of the National Cancer Institute, 2005
- Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test ResultsJAMA, 2005
- Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical CancerNew England Journal of Medicine, 1999
- Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, UgandaThe Lancet, 1995
- The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcriptionVirus Research, 1993
- Human Immunodeficiency Virus Infection among Patients Attending Clinics for Sexually Transmitted DiseasesNew England Journal of Medicine, 1988